Zobrazeno 1 - 10
of 698
pro vyhledávání: ''
Autor:
Xiao Xiao, Wei-Xiong Xia, Shaomin Huang, Jingjing Miao, Fei Han, Lin Wang, Xiang Guo, Yan-Qun Xiang, Chong Zhao, Yinglin Peng, Boyu Chen, Xiaowu Deng, Huageng Huang, Xing Lv, Yingshan Liang, Manyi Zhu, Weiwei Xiao
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study was aimed to investigate long-term survivals and toxicities of early-stage nasopharyngeal carcinoma (NPC) in endemic area, evaluating the role of chemotherapy in stage II patients.Materials and Methods Totally 187 patients with new
Autor:
Hideo Baba, Yusuke Taniyama, Naoya Yoshida, Kozue Takahashi, Kentaro Murakami, Takashi Kamei, Hisahiro Matsubara
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background Evaluating the effect on primary lesions is important in determining treatment strategies for esophageal cancer. The Response Evaluation Criteria in Solid Tumors system, which employs the longest diameter for measuring tumors, is commonly
Autor:
Stéphane Oudard, Brigitte Laguerre, Carole Helissey, Mathilde Cancel, Diego Teyssonneau, Pierre Emmanuel Brachet, Edouard Auclin, Constance Thibault, Philippe Barthélémy, Johanna Noel, Cedric Pobel, Denis Maillet, Elouen Boughalem
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6304-6309 (2021)
Cancer Medicine
Cancer Medicine
Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it.
Autor:
Qingyang Wang, Andrew Keller, Jessie Y. Li, Irina Dimitrova, Sushil Beriwal, Eric Leung, Lara Hathout, Andrea L. Russo, Elizabeth A. Kidd, Mohamed A. Elshaikh, Junzo Chino, Shruti Jolly, Elysia Donovan, Shari Damast, Larissa J. Lee, E. Jaworski, Irina Vergalasova, Melissa Usoz, Neil K. Taunk, Divya Natesan, Yaqun Wang, Emma C. Fields, Kevin Albuquerque, Jayanthi S. Lea
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:1423-1431
Our purpose was to evaluate the effect of sequence and type of adjuvant therapy for patients with stage IIIC endometrial carcinoma (EC) on outcomes.In a multi-institutional retrospective cohort study, patients with stage IIIC EC who had surgical stag
Autor:
Saad Sheikh, Sujay Datta, Tithi Biswas, Charulata Jindal, Mitchell Machtay, Tarun Podder, Afshin Dowlati, Asoke Dey, Jimmy T. Efird
Publikováno v:
Future Oncology. 17:2713-2724
The role of prophylactic cranial irradiation (PCI) and thoracic radiation therapy (TRT) in extensive-stage small cell lung cancer remains controversial. The authors examined the National Cancer Database and identified patients with extensive-stage sm
Autor:
Dooreh Kim, Jee Ye Kim, Byeong Woo Park, Seung Il Kim, Joon Jeong, Soong June Bae, Janghee Lee, Chihwan Cha, Hyung Seok Park, Soeun Park, Seho Park, Sung Gwe Ahn
Publikováno v:
International Journal of Cancer
Incorporating dual human epidermal growth factor receptor 2 (HER2) blockade into neoadjuvant systemic therapy (NST) led to higher response in patients with HER2‐positive breast cancer. However, axillary response to treatment regimens, including sin
Autor:
Shengmin Chen, Weifeng Wang, Huanliang Wu, Feng Yuan, Zhiren Lin, Gang Cheng, Shaohua Peng, Yunxiu Luo
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:2913-2922
Assessing the downstaging effects of neoadjuvant chemotherapy (NACT) in patients with locally advanced nasopharyngeal carcinoma (LANPC) and predicting response to treatment remain challenging. The present study aimed to evaluate the long-term prognos
Autor:
Xiangjuan Ma, Di Wu, Jieran Long, Guangming Tian, Jian Fang, Jindi Han, Yang Wang, Ziran Zhang, Jie Zhang, Jun Nie, Weiheng Hu, Sen Han, Ling Dai, Xiaoling Chen
Publikováno v:
Cancer Immunology, Immunotherapy
Background The combination of PD-1/PD-L1 inhibitor and chemotherapy has been clinically confirmed to be beneficial as the first-line treatment of patients with advanced NSCLC. This study aimed to assess the effect of nivolumab + docetaxel versus nivo
Publikováno v:
Future Oncology. 17:2183-2192
Aim: To investigate the benefit of chemotherapy among early-stage breast cancer patients with 21-gene recurrence scores of 26–30. Methods: We identified 3754 patients in the Surveillance, Epidemiology, and End Results database. Results: 57.6% of th
Autor:
Claudia Milena Agudelo, Sonia M. Hernandez, Vladimir Avila, Juan Felipe Combariza, Ana María Madera, Jaime Valdés, Leonardo Bautista, Fabián Andrés Mejía, Liliana Moreno, Rocio Orduz, Guillermo León, Marcos Arango, Carlos Alberto García Ramírez, Laura Díaz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e365-e372
Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse. The objective of the study was to assess disease-free survival (DFS) and overall survival (OS) of patien